Cats are famously difficult to medicate. They resist handling, detect tablets hidden in food with uncanny accuracy, and react to topical treatments by immediately attempting to groom them off. This biological resistance to treatment has long complicated feline parasite control, making long-duration topical treatments genuinely transformative for cat owners. Bravecto for cats – specifically the Bravecto Plus formulation – represents one of the most significant advances in this space available to New Zealand cat owners. A single spot-on application provides three months of flea and tick protection alongside moxidectin coverage for roundworms, hookworms, and ear mites.
The real-world value of a three-month product for cats goes beyond mere convenience. Every treatment administration is a stress event for both cat and owner. Reducing twelve annual handling events to four is not a trivial quality-of-life improvement – it is a meaningful reduction in a form of chronic low-level stress that accumulates for both parties over a year of monthly treatment. Cats that are difficult to treat often end up undertreated as owners avoid the confrontation, leaving gaps in parasite protection that are entirely preventable with a longer-duration product.
The Two Active Compounds in Bravecto Plus
Bravecto Plus contains two active compounds working through complementary mechanisms. Fluralaner handles flea and tick protection through the GABA receptor disruption mechanism that kills parasites when they bite the treated animal. Its systemic distribution via the bloodstream provides whole-body coverage without any region of the cat being unprotected. Moxidectin, the second active compound, extends coverage to internal parasites – specifically roundworms (Toxocara cati), hookworms, and ear mites (Otodectes cynotis).
The ear mite coverage from moxidectin is worth specific attention. Otodectes cynotis causes significant ear canal irritation and secondary infection in cats, particularly in multi-cat households where transmission between animals is common. Monthly treatment schedules with products that do not cover ear mites may miss this parasite entirely, requiring separate treatment when an infestation develops. Bravecto Plus addresses ear mites as part of the standard quarterly application, preventing establishment before symptoms develop.
Understanding the Three-Month Duration
The three-month protection window reflects fluralaner’s pharmacokinetics – the same fat-tissue accumulation and gradual release that gives Bravecto dog chewables their twelve-week duration. After topical application to the skin, fluralaner is absorbed through the skin surface and enters the bloodstream, where it distributes into fat deposits and is gradually released over time. The moxidectin component has a somewhat shorter efficacy window, which is why the product is specified for application every three months rather than every four to maintain consistent coverage across all components.
For New Zealand cat owners, this three-month cycle translates to four applications per year. Compared to twelve monthly applications, this is a significant reduction in the number of treatment events and in the annual purchasing decisions required. Many owners align their four annual applications with the changes of season – an easy memorable anchor for a quarterly schedule.
Application: Getting It Right Every Time
The spot-on is applied to the back of the neck – the one location cats cannot easily reach to lick. Part the fur firmly to expose the skin, place the tip of the applicator directly against the skin surface, and express the contents in a single application. The product must contact skin rather than sitting on top of the fur coat; application to fur significantly reduces absorption and therefore efficacy. After application, cats should be kept dry for forty-eight hours to allow initial skin absorption.
Beyond that initial window, the systemic nature of fluralaner means water exposure does not meaningfully affect the ongoing protection – the active compound is already in the bloodstream and fat tissue, not on the coat surface. Some cat owners notice a slight greasiness or altered coat texture at the application site for a day or two after treatment; this is normal and resolves as the product distributes.
Indoor Cats: Still Worth Protecting
A common question from owners of indoor-only cats is whether flea treatment is necessary. The answer in most cases is yes. Fleas can enter homes on clothing, shoes, and through visiting animals. In multi-storey buildings, they can travel between apartments through shared spaces. An indoor-only cat is not automatically a protected cat, particularly in urban New Zealand where shared building spaces create transfer pathways that owners may not consider. For the roundworm and ear mite components, indoor cats face lower but not zero risk depending on their specific living situation.
For cats that do go outdoors, the parasite exposure risk is substantially higher – hunting behaviour alone creates significant tapeworm and roundworm risk on top of the baseline flea exposure. Bravecto Plus addresses the most common parasite threats for both indoor and outdoor New Zealand cats in a single quarterly application.
What Bravecto Plus Does Not Cover
Bravecto Plus does not cover all tapeworm species. The flea tapeworm (Dipylidium caninum) is addressed indirectly through flea control – no fleas means no flea-tapeworm transmission – but other tapeworm species acquired through hunting require a separate praziquantel-containing product. For cats that hunt regularly, periodic tapeworm treatment in addition to regular Bravecto Plus provides complete parasite coverage. Discussing your specific cat’s risk profile – lifestyle, hunting behaviour, geographic location – with a veterinarian will clarify whether and how often additional tapeworm treatment is warranted.
Both formulations of Bravecto for cats – for animals under and over 2.5 kilograms – are available through veterinary clinics and authorised pet supply NZ online retailers. As a prescription-only product, a veterinary prescription is required. Purchasing the correct weight-range formulation is important for both safety and efficacy.